Sweden’s MedCap posts strong quarterly profit on acquisitions and organic growth
STOCKHOLM: Swedish medical technology and life sciences investor MedCap AB on Friday reported a 32% rise in its third-quarter adjusted core earnings, driven by robust organic growth and contributions from recent acquisitions. The company, which buys and develops small- and…